Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America [Phase 2]

View source ↗

Summary

Phase 2 trial update on immunogenicity and safety of Sanofi Pasteur's CYD Dengue vaccine in healthy children and adolescents in Latin America; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Fever
• Dengue Hemorrhagic Fever
• Dengue Virus

Drugs mentioned

• CYD Dengue vaccine (dengue vaccine, live attenuated tetravalent)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue, Dengue Hemorrhagic Fever | Phase 2 | Status: COMPLETED | Results posted: 2016-11-29